AGP Executive Report
Last update: 11 hours agoCBD Medicare/Medicaid Push: The FDA says it won’t interfere with CMS coverage for certain hemp-derived CBD products, with limits like 0.3% delta-9 THC and small total-THC caps (oral forms only). Travel Rules: TSA updated medical marijuana guidance, clarifying what patients can bring and urging people to separate treatment from flying. Drug Enforcement: Indonesia’s BNN is probing an international trafficking network after Russian nationals were arrested in Bali with about 7.8kg of narcotics, with investigators tracing distribution lines. Local Cannabis in the Mix: Sri Lanka’s STF seized 227kg of “Kerala cannabis” in separate recoveries, including parcels hidden roadside and in a lagoon. Market Watch: Tilray’s Brewdog deal is framed as a pivot toward “brand manager” ambitions, but UK sales weakness raises doubts. Health & Safety: A doctor’s Q&A warns that spirometer numbers don’t diagnose COPD, and stresses proper lung-function testing—especially for people with tobacco and cannabis histories.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.